Detalhe da pesquisa
1.
Effects of injectable extended-release naltrexone (XR-NTX) for opioid dependence on residential rehabilitation outcomes and early follow-up.
Am J Addict
; 24(3): 265-270, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25655226
2.
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.
Lancet
; 377(9776): 1506-13, 2011 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21529928
3.
Thirty Years of TheASAMCriteria: A Report Card.
Psychiatr Clin North Am
; 45(3): 593-609, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055741
4.
Practical Technology for Expanding and Improving Substance Use Disorder Treatment: Telehealth, Remote Monitoring, and Digital Health Interventions.
Psychiatr Clin North Am
; 45(3): 515-528, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055736
5.
Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
Alcohol Clin Exp Res
; 35(10): 1804-11, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21575016
6.
Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexone.
Am J Addict
; 20(2): 106-12, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21314752
7.
Effects of naltrexone treatment for alcohol-related disorders on healthcare costs in an insured population.
Alcohol Clin Exp Res
; 34(6): 1090-7, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20374204
8.
Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patients.
Alcohol Clin Exp Res
; 33(2): 350-6, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19053979
9.
Decreased absolute amygdala volume in cocaine addicts.
Neuron
; 44(4): 729-40, 2004 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-15541319
10.
Overriding the blockade of antinociceptive actions of opioids in rats treated with extended-release naltrexone.
Pharmacol Biochem Behav
; 89(4): 515-22, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18342360
11.
Injectable extended-release naltrexone for opioid dependence.
Lancet
; 378(9792): 665; author reply 666, 2011 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21856477
12.
Reduction in heavy drinking as a treatment outcome in alcohol dependence.
J Subst Abuse Treat
; 33(1): 71-80, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17588491
13.
Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals With Opioid Dependence.
J Addict Med
; 11(3): 224-230, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28358754
14.
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
JAMA
; 295(17): 2003-17, 2006 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-16670409
15.
A Naturalistic Evaluation of Extended-Release Naltrexone in Clinical Practice in Missouri.
J Subst Abuse Treat
; 70: 50-57, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27692188
16.
Prevalence of physical and sexual abuse among substance abuse patients and impact on treatment outcomes.
Drug Alcohol Depend
; 78(1): 57-64, 2005 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-15769558
17.
The effect of 12-step self-help group attendance and participation on drug use outcomes among cocaine-dependent patients.
Drug Alcohol Depend
; 77(2): 177-84, 2005 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-15664719
18.
Developing a baseline assessment battery: balancing patient time burden with essential clinical and research monitoring.
J Stud Alcohol Suppl
; (15): 94-103; discussion 92-3, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16223061
19.
Factorial designs in clinical trials: options for combination treatment studies.
J Stud Alcohol Suppl
; (15): 24-32; discussion 6-7, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16223053
20.
Design and analysis of trials of combination therapies.
J Stud Alcohol Suppl
; (15): 34-42; discussion 33, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16223054